Trial · NCT04622709
Results by group208
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 208
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 5 | Study Drug Administration: Furosemide | 33 | percentage of participants | ||
| Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 12 | Study Drug Administration: Furosemide | 33 | Percentage of participants | ||
| Percentage of Participants Who Have a Defined Increase in 24-hour Urine Volume From Baseline to Week 18 | Study Drug Administration: Furosemide | 22 | Percentage of participants | ||
| Percentage of Participants With A Serum Potassium <3.2 mEq/L at Week 1 | Study Drug Administration: Furosemide | 0 | percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 2 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 3 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 4 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 5 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 6 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 9 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 13 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Potassium <3.2 mEq/L at Week 17 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 1 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 2 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 3 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 4 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 5 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 6 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 9 | Study Drug Administration: Furosemide | 0 | Percentage of participants | ||
| Percentage of Participants With a Serum Magnesium <0.8 mEq/L at Week 13 | Study Drug Administration: Furosemide | 0 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04622709/results